Abstract
Medicinal plants or Chinese materia medica (CMM) are now attracting worldwide attention as they have increasingly prominent advantages over chemical drugs in disease treatment and healthcare. Since the 1990s, World Health Organization (WHO) and International Organization for Standardization established the Technical Committee of Traditional Chinese Medicine (ISO/TC 249) have carried out the development of quality standards on medicinal plants or CMMs respectively, and a considerable number of monographs and international standards have been published. Since the two international organizations adhere to different principles, the standards they develop naturally have different emphasis. Driven by market demand and international trade, ISO mainly takes quality, efficacy and safety into consideration when developing standards, while WHO pays more attention to clinical practice, quality control and medication guidance. Up to now, there is a lack of comparative analysis on the records, background, principles, basic content, and main requirements of quality standards on medicinal plants or CMMs respectively published by WHO and ISO. Therefore, based on international standards of CMM developed by ISO/TC 249 platform and WHO Monographs on Selected Medicinal Plants, this paper systematically compares the purposes, selected principles, standard-developing process, basic content, and main quality requirements to summarize their similarities and differences, and find their merits, aiming to serve as a reference to the development of international standards for CMMs that helps them go global.
Similar content being viewed by others
References
Wang YX, Shi NN, Liu YQ, Han XJ, Wang YP. Analysis and suggestion on standardization progression of ISO/TC249 traditional Chinese medicine. World J Integr Tradit West Med (Chin) 2015;10:1745–1747.
The State Council Information Office of the People’s Republic of China. Traditional Chinese medicine in China. Available at: http://www.scio.gov.cn/ztk/dtzt/34102/35624/35628/Document/1534664/1534664.html. Accessed 26 March 2020.
Zhu L. Challenges, opportunities and promoting strategies of the international development of Chinese traditional medicine industry. Pract Foreign Econ Relat Trade (Chin) 2020;11:57–60.
Liu Y, Yu ZB. Analysis of TCM import and export situation in 2019. Mod Chin Med (Chin) 2020;22:342–347.
Cheng M, Yang G. Current situation of traditional Chinese medicine market. China Food Drug Adm Mag (Chin) 2019;5:62–67.
Leong F, Hua X, Wang M, Chen T, Song Y, Tu P, et al. Quality standard of traditional Chinese medicines: comparison between European Pharmacopoeia and Chinese Pharmacopoeia and recent advances. Chin Med 2020;15:76.
Jiang ZJ, Zhang HM, Yu ZB, Li DY. International market standards for exports of Chinese medicinal materials. Mod Chin Med (Chin) 2018;20:217–238.
Tong YY, He W, Zhao YK. Review of WHO’s guidelines on traditional Chinese medicine. Chin J Inform Tradit Chin Med (Chin) 2010;17:2–3.
Yuan Y. Research on WHO’s guidelines on traditional Chinese medicine[dissertation]. Chongqing: Chongqing Medical University; 2016.
World Health Organization. WHO Monographs on Selected Medicinal Plants (Vol.1–4). Available at: https://apps.who.int/iris/handle/10665/42052?locale-attribute=en&mode=full
ISO. ISO/TC 249 Traditional Chinese medicine. [Accessed 2021-08-31]. Available at: https://www.iso.org/committee/598435.html.
Hu YM. Overview of WHO standards for traditional Chinese medicine. China Information Conference of Traditional Chinese Medicine, 2006.
Li J, Zhu J, Hu H, Harnett JE, Lei CL, Chau KY, et al. Internationalization of Traditional/Complementary Medicine products: market entry as medicine. Chin Med 2018;13:50.
Zhang XQ, Xiong Y, Huang QQ, Zou WJ, Qu LP. Analysis of WHO monographs on selected medicinal plants. Chin Tradit Pat Med (Chin) 2019;41:2192–2196.
ISO. ISO/IEC directives, Part 1. Consolidated ISO supplement—procedures specific to ISO. 2020. [Accessed 2021-08-08]. Available at: https://www.iso.org/directives-and-policies.html.
Huang YF, He F, Xie Y, Liu L, Zhou H. ISO/TC 249 platform promotes the development of international standardization and trade for the Chinese medicines industry. Pharmacol Res 2020;160:105066.
Author information
Authors and Affiliations
Contributions
Yang JY and Shi YH drafted the manuscript and prepared the tables and figure. San Z and Wang R contributed to the critical revisions of the manuscript. Huang YR, as corresponding author, and Shi YH designed the study and developed the manuscript. All authors read and approved the final manuscript for publication.
Corresponding author
Additional information
Conflict of Interest
All authors declared no conflict of interests regarding the publication of this paper.
Supported by the National Social Science Fund of China (No. 19CGJ037), Three-Year Action Plan for Development of Traditional Chinese Medicine in Shanghai [No. ZY(2021–2023)-0212], Shanghai Association for Science and Technology (No. 20DZ2200800), Shanghai University of Traditional Chinese Medicine Xinglin Talent Plan
Rights and permissions
About this article
Cite this article
Yang, Jy., Sang, Z., Wang, R. et al. Characterization and Comparison Analysis of WHO Monographs on Selected Medicinal Plants and ISO Standards of Chinese Materia Medica. Chin. J. Integr. Med. 29, 540–548 (2023). https://doi.org/10.1007/s11655-022-3526-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-022-3526-7